180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance With Continued Listing Requirements
180 life sciences獲得納斯達克聽證會的額外延期,以符合持續上市要求
180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance With Continued Listing Requirements
180 life sciences獲得納斯達克聽證會的額外延期,以符合持續上市要求
譯文內容由第三人軟體翻譯。